Instructions for Isla-mint lozenges 100 mg blister No. 30
Composition
active ingredient: aqueous extract of Icelandic moss;
1 lozenge contains 100 mg of aqueous extract of Iceland moss (Iceland moos) ((2-4):1); extractant: water; contains sorbitol solution (1:2);
excipients: sorbitol non-crystallizing solution (E 420); aspartame (E 951), gum arabic, peppermint oil, copper complexes of chlorophylls (E 141), light mineral oil, purified water;
1 lozenge contains 0.385 g of carbohydrates, which corresponds to 0.03 bread units.
Dosage form
Lozenges.
Main physicochemical properties: flat, irregularly rounded, lenticular, green gummy pastilles with peppermint flavor; the presence of air bubbles is allowed.
Pharmacotherapeutic group
Drugs used in throat diseases. ATX code R02A.
Pharmacological properties
Pharmacodynamics
The medicine contains an extract from the medicinal plant Cetraria islandica (Icelandic moss), which is known for its therapeutic effect in inflammatory diseases of the respiratory tract.
The therapeutic effect of the drug in catarrhal diseases of the respiratory tract is based on the antimicrobial activity and immunostimulating properties of the plant extract contained in it, which is proven by the results of scientific research. The polysaccharides contained in the drug envelop the mucous membranes of the respiratory tract and effectively protect them from the effects of harmful external factors and various types of irritants. Since the drug also has protective properties, it can also be used for preventive purposes, including when playing sports.
Prophylactic use of the drug can protect the mucous membranes and reduce the susceptibility of the respiratory tract to infections. The drug does not irritate the stomach.
Pharmacokinetics
Data is missing.
Indication
Cough, including bronchitis; hoarseness (laryngitis, pharyngitis); bronchial asthma (as an adjuvant). Increased load on the vocal cords (in singers, teachers, lecturers).
Dryness of the mucous membranes in dry air in living rooms or in insufficiently humidified office spaces during the heating season, as well as with limited nasal breathing or during sports activities.
Contraindication
Hypersensitivity to the active substance or other components of the medicinal product.
Fructose intolerance.
Interaction with other medicinal products and other types of interactions
Unknown until now.
Application features
If you have phenylketonuria, it is important to note that the medicinal product contains the sweet substance aspartame (E 951).
If you have fructose intolerance, please note that the medicine contains the sweetener sorbitol (E 420).
The plant extracts contained in the medicine can sometimes cause deviations in the color and taste of this medicine, which does not affect its therapeutic effect.
The drug Isla-Mint does not contain sugar, so it can be prescribed to patients suffering from diabetes.
1 lozenge corresponds to 0.03 bread units = 0.385 g of carbohydrates.
Use during pregnancy or breastfeeding
There is no information on the negative effects of the drug during pregnancy or breastfeeding. However, special studies have not been conducted in this category of patients, so the risk/benefit ratio should be weighed before using the drug.
Ability to influence reaction speed when driving vehicles or other mechanisms
If the drug is taken according to these instructions, no negative consequences of its use are expected.
Method of administration and doses
Adults and children over 12 years of age should take 1 lozenge every hour (up to 12 lozenges per day), children aged 4 to 12 years - 1 lozenge every 2 hours (up to 6 lozenges per day), allowing them to slowly dissolve in the mouth.
Isla-Mint can be used for a long time.
Even after the symptoms of the disease disappear, Isla-Mint should be taken for several more days in order to achieve a lasting therapeutic effect.
If persistent symptoms of the disease do not decrease within 4-5 days or, on the contrary, worsen, shortness of breath, fever, as well as purulent sputum and sputum with blood appear, you should immediately consult a doctor.
Children.
The drug should be prescribed to children over 4 years of age, as the lozenges must be held in the mouth, allowing them to dissolve slowly.
Overdose
There have been no reports of overdose.
Side effects
In rare cases, allergic reactions may occur.
Very rarely, the drug may have a laxative effect in sensitive patients, as it contains sorbitol.
Expiration date
4 years.
Do not use after the expiry date stated on the packaging.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 °C, out of the reach of children.
Packaging
Vacation category
Without a prescription.
Producer
Engelhard Arzneimittel GmbH & Co. KG/Engelhard Arzneimittel GmbH & Co. KG.
Address
Herzbergstrasse 3, 61138 Niederdorfelden, Germany.
